Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MEDI2228 |
Synonyms | |
Therapy Description |
MEDI2228 is an antibody-drug conjugate comprising a BCMA targeted antibody linked to a pyrrolobenzodiazepine dimer, which delivers the DNA cross-linking agent to BCMA-expressing tumor cells, potentially resulting in decreased tumor growth (Blood (2017) 130 (Supplement 1): 3153, PMID: 32060401). |